NARIDO RICHARD CLAVANO (Interim CFO) sold 27.4% of their position (29.38K shares) of LUCIRA HEALTH, INC. on the open market
Open‑market sale worth $29.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 3/13/2023ACC: 0001209191-23-018225
Officer· Interim CFO
Since Nov 2022
-29.38K
Net shares
Net seller
$29.4K
Total sold
5
Open market trades
0B · 5S
5
Total transactions
29.38K disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
−10.67K
Price / share
$1.14
Trade value
$12.17K
% of position
9.9%
3/3/2023
107.29K→96.62K
Common Stock
Direct
Shares
−9.68K
Price / share
$1.07
Trade value
$10.35K
% of position
10.0%
3/3/2023
96.62K→86.94K
Common Stock
Direct
Shares
−4.74K
Price / share
$1.00
Trade value
$4.74K
% of position
5.5%
3/3/2023
86.94K→82.20K
Common Stock
Direct
Shares
−1.91K
Price / share
$0.57
Trade value
$1.09K
% of position
2.3%
3/6/2023
82.20K→80.29K
Common Stock
Direct
Shares
−2.38K
Price / share
$0.45
Trade value
$1.07K
% of position
3.0%
3/7/2023
80.29K→77.91K
Total
Net shares
−29.38K
Net value
-$29.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/3/2023 | S · Sale | −10.67K | $1.14 | $12.17K | 9.9% | 107.29K | 96.62K |
| Common Stock Direct | 3/3/2023 | S · Sale | −9.68K | $1.07 | $10.35K | 10.0% | 96.62K | 86.94K |
| Common Stock Direct | 3/3/2023 | S · Sale | −4.74K | $1.00 | $4.74K | 5.5% | 86.94K | 82.20K |
| Common Stock Direct | 3/6/2023 | S · Sale | −1.91K | $0.57 | $1.09K | 2.3% | 82.20K | 80.29K |
| Common Stock Direct | 3/7/2023 | S · Sale | −2.38K | $0.45 | $1.07K | 3.0% | 80.29K | 77.91K |
| Total | −29.38K | -$29.42K | ||||||
Derivative Transactions0
No derivative transactions reported